SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe

Dataset

Abstract

In order to protect health workers from SARS-CoV-2, there is need to characterise the different types of patient-facing health workers. These data were collected to determine both the infection and seroprevalence of SARS-COV-2 in health workers as well as to evaluate the occupational and demographic predictors of seropositivity to inform the country’s infection prevention and control strategy. The data presented here were collected from 651 health workers in Zimbabwe. The participants were recruited through a mixed sampling approach was to allow the study to capture different types of patient-facing worker in different health care settings. Their demographic data (age, sex) and type of health centre, occupation, and station in the health centres is provided. Also collected were health variables which are self-explanatory in the data spread sheet. These include the following; COVID-19 symptoms in the previous 4 months e.g. fever recorded as fever_4months in the spread sheet as well as COVID-19 symptoms at the time of the study recorded as fever, new dry cough etc and, self-reported co-morbidities recorded at the time of collection are also given e.g. diabetes, cancer where yes means co-morbidity or symptom is present and no means the co-morbidity or symptom is not present in the participant. We determined the serological status of the health workers by detecting the presence of SARS CoV-2 antibodies using a rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies (Wuhan UNscience Biotechnology Companies UNICOV-40 test kit) following the manufacturer’s guidelines. The test detects the presence of IgM and IgG antibodies directed against the nucleocapsid and the spike proteins of the virus. The IgM antibody status is recorded in the spreadsheet under the variable SARSCOV2 IgM antibody_result, where negative means no IgM antibodies were detected and positive means IgM antibodies were detected. The IgG antibody status is recorded in the spreadsheet under the variable SARSCOV2 IgG antibody_result, where negative means no IgG antibodies were detected and positive means IgG antibodies were detected.

Data Citation

Mutapi, Francisca. (2021). SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe, 2020 [text]. University of Edinburgh. https://doi.org/10.7488/ds/2998.
Date made available1 Dec 2021
PublisherEdinburgh DataShare
Temporal coverage9 Jun 2020 - 9 Jun 2020
Geographical coverageBulawayo,ZW,ZIMBABWE

Cite this